This ruling resolves all issues in this case with Mannatech winning on all patent and trademark infringement claims brought against Glycoproducts International (Glycobiotics).
The judge also entered a broad permanent injunction against Glycobiotics and related parties enjoining them from ‘making, using, offering to sell, selling, or otherwise distributing within the US, or importing into the US, defendant’s product, Glycomannan, as well as colorable imitations thereof, including, without limitation, products that are substantially equivalent in composition to Glycomannan, and any other products that infringe the Mannatech’s patents.”
The injunction goes on to prohibit Glycobiotics from inducing others to infringe or assisting others in the infringement of these patents. Glycobiotics must also take all Glycomannan in its control, and make every reasonable effort to re-acquire all such product from any third party, and deliver such product to Mannatech for destruction. Finally, Glycobiotics is prohibited from falsely advertising the nature, characteristics or qualities of Mannatech’s glyconutritional products.
Keith Clark, Mannatech’s senior vice president and general counsel, said: “We are now vigorously pursuing all damages that can be awarded by the court by virtue of these infringements on our patents. We did not compromise to this point and we intend to fully recover everything to which we are entitled.”